Inclusion of methoxybutropate in β- and hydroxypropyl β-cyclodextrins: Comparison of preparation methods

Drug Development and Industrial Pharmacy

Volumn 23, Issue 1, 1997, Pages 27-37

  Palmieri, Giovanni Filippo ^a   Galli Angeli, Depalmo ^b   Giovannucci, Gaetana ^a   Martelli, Sante ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

^b Università Politecnica delle Marche ACRAF Gruppo Angelini   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; BETA CYCLODEXTRIN; METOXIBUTROPATE;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TECHNIQUE; X RAY DIFFRACTION;

EID: 0031027835     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.3109/03639049709148479     Document Type: Article

References (24)

1. J. Szejtli, Cyclodextrin Technology, Kluwer, Dordrecht, 1988.
2. S. Y. Lin and Y. H. Kao, Int. J. Pharm., 56, 249-259 (1989).
3. F. Kedzierewicz, M. Hoffmann, and P. Maincent, Int. J. Pharm., 58, 221-227 (1990).
4. G. Puglisi, N. A. Santagati, R. Pignatello, C. Ventura, F. A. Bottino, S. Mangiafico, and G. Mazzone, Drug Dev. Ind. Pharm., 16, 395-413 (1990).
5. M. A. Hassan, M. S. Suleiman, and N. M. Najib, Int. J. Pharm., 58, 19-24 (1990).
6. S. Z. Lin, D. Wouessidjewe, M. C. Poelman, and D. Duchêne, Int. J. Pharm., 69, 211-219 (1991).
7. C. Torricelli, A. Martini, L. Muggetti, and R. De Ponti, Int. J. Pharm., 71, 19-24 (1991).
8. X. Tan and S. Lindenbaum, Int. J. Pharm., 74, 127-135 (1991).
9. M. G. Fucile, G. Mazzitelli D. Ratti, and F. Pozzi, Eur. J. Pharm. Biopharm., 38, 140-144 (1992).
10. S. Anguiano-Igea, F. J. Otero-Espinar, J. L. Vila-Jato, and J. Blanco-Méndez, STP Pharma Sci., 2, 325-331 (1992).
11. G. F. Palmieri, P. Wehrlé, G. Duportail, and A. Stamm, Drug Dev. Ind. Pharm., 18, 2117-2121 (1992).
12. G. F. Palmieri, P. Wehrlé, and A. Stamm, Drug Dev. Ind. Pharm., 19, 875-885 (1993).
13. J. Pitha, J. Milecki, H. Fales, L. Pannel, and K. Uekama, Int. J. Pharm., 29, 73-82 (1986).
14. T. Loftsson, S. Björnsdóttir, G. Pálsdóttir, and N. Bodor, Int. J. Pharm., 57, 63-72 (1989).
15. R. T. Darrington, T. X. Xiang, and B. D. Anderson, Int. J. Pharm., 59, 35-44 (1990).
16. T. X. Xiang and B. D. Anderson, Int. J. Pharm., 59, 45-55 (1990).
17. K. Dietzel, K. S. Ester, M. E. Brewster, N. S. Bodor, and H. Derendorf, Int. J. Pharm., 59, 225-230 (1990).
18. K. S. Estes, M. E. Brewster, A. I. Webb, and N. Bodor, Int. J. Pharm., 65, 101-107 (1990).
19. T. Loftsson and B. Ólafsdóttir, Int. J. Pharm., 66, 289-292 (1990).
20. A. Yoshida, M. Yamamoto, T. Itoh, T. Irie, F. Hirayama, and K. Uekama, Chem. Pharm. Bull., 38, 176-179 (1990).
21. M. Krenn, M. P. Gamcsik, G. B. Vogelsang, O. M. Colvin, and K. W. Leong, J. Pharm. Sci., 81, 685-689 (1992).
22. C. J. Betlach, M. A. Gonzalez, B. C. McKiernan, C. Neff-Davis, and N. Bodor, J. Pharm. Sci., 82, 1058-1060 (1993).
23. T. Järvinen, K. Järvinen, N. Schwarting, and V. J. Stella, J. Pharm. Sci., 84, 295-299 (1995).
24. T. Higuchi and K. A. Connors, Adv. Chem. Instr., 4, 117 (1965).